TP53BP2 Antikörper (AA 1001-1128)
-
- Target Alle TP53BP2 Antikörper anzeigen
- TP53BP2 (Tumor Protein P53 Binding Protein 2 (TP53BP2))
-
Bindungsspezifität
- AA 1001-1128
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TP53BP2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Human, Maus
- Homologie
- Rat,Chicken
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human ASPP2
- Isotyp
- IgG
- Top Product
- Discover our top product TP53BP2 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study." in: Chinese journal of cancer, Vol. 36, Issue 1, pp. 15, (2017) (PubMed).
: "
-
Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study." in: Chinese journal of cancer, Vol. 36, Issue 1, pp. 15, (2017) (PubMed).
-
- Target
- TP53BP2 (Tumor Protein P53 Binding Protein 2 (TP53BP2))
- Andere Bezeichnung
- ASPP2/p53BP2 (TP53BP2 Produkte)
- Synonyme
- 53BP2 antikoerper, ASPP2 antikoerper, BBP antikoerper, P53BP2 antikoerper, PPP1R13A antikoerper, TP53BP2 antikoerper, AI746547 antikoerper, Tp53bp2 antikoerper, X98550 antikoerper, Trp53bp2 antikoerper, wu:fa09h08 antikoerper, wu:fb04e08 antikoerper, zgc:85720 antikoerper, tumor protein p53 binding protein 2 antikoerper, tumor protein p53 binding protein 2 L homeolog antikoerper, tumor protein p53 binding protein, 2b antikoerper, transformation related protein 53 binding protein 2 antikoerper, tumor protein p53 binding protein, 2 antikoerper, tumor protein p53 binding protein, 2a antikoerper, TP53BP2 antikoerper, tp53bp2.L antikoerper, tp53bp2 antikoerper, tp53bp2b antikoerper, Trp53bp2 antikoerper, Tp53bp2 antikoerper, tp53bp2a antikoerper
- Hintergrund
-
Synonyms: BBP, 53BP2, ASPP2, P53BP2, PPP1R13A, Apoptosis-stimulating of p53 protein 2, Bcl2-binding protein, Renal carcinoma antigen NY-REN-51, Tumor suppressor p53-binding protein 2, p53-binding protein 2, TP53BP2
Background: Regulator that plays a central role in regulation of apoptosis and cell growth via its interactions. Regulates TP53 by enhancing the DNA binding and transactivation function of TP53 on the promoters of proapoptotic genes in vivo. Inhibits the ability of APPBP1 to conjugate NEDD8 to CUL1, and thereby decreases APPBP1 ability to induce apoptosis. Impedes cell cycle progression at G2/M. Its apoptosis-stimulating activity is inhibited by its interaction with DDX42.
- Gen-ID
- 7159
- UniProt
- Q13625
-